menu
    • menu

    Company profile for Newleos Therapeutics

    NEW Drugs in Dev: 2
    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    Evonik Health Care is the innovation hub for leading life science companies

    Virtual Booth

    Contact Supplier

    Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

    Virtual Booth

    Contact Supplier

    Axplora is your partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Newleos Therapeutics is pioneering next-generation therapies for mental health conditions, focusing on anxiety and substance use disorders—two major areas of unmet medical need. Our clinical-stage pipeline, licensed from Roche, includes oral small molecules targeting GABAA-γ1, V1a, TAAR1, and GABAA-α5, with broad potential in anxiety, substance use, and cognitive impairment. Co-founded by Longwood Fund, Dr. Federico Bologn...
    Newleos Therapeutics is pioneering next-generation therapies for mental health conditions, focusing on anxiety and substance use disorders—two major areas of unmet medical need. Our clinical-stage pipeline, licensed from Roche, includes oral small molecules targeting GABAA-γ1, V1a, TAAR1, and GABAA-α5, with broad potential in anxiety, substance use, and cognitive impairment. Co-founded by Longwood Fund, Dr. Federico Bolognani, and Dr. William Martin, Newleos is dedicated to delivering first- and best-in-class treatments for neuropsychiatric disorders.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Newleos TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    800 Boylston St, Ste 1715 Boston, MA 02199
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://newleos.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    BePharma

    Not Confirmed

    envelop Contact Supplier

    BePharma

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Newleos Doses First Patient in SOAR Phase 2 Anxiety Study
    Newleos Doses First Patient in SOAR Phase 2 Anxiety Study

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106866335/en/Newleos-Therapeutics-Announces-Dosing-of-First-Participant-in-SOAR-Phase-2-Study-of-NTX-1472-for-Social-Anxiety-Disorder

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Newleos Therapeutics Names Timothy Noyes President, CEO
    Newleos Therapeutics Names Timothy Noyes President, CEO

    21 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-21/newleos-therapeutics-appoints-timothy-noyes-as-president-and-chief-executive-officer

    PHARMIWEB
    21 Oct 2025
    Share Share
    Newleos Pharma CEO Donabedian Honored By Goldman Sachs At 2025
    Newleos Pharma CEO Donabedian Honored By Goldman Sachs At 2025

    15 Oct 2025

    // PHARMIWEB

    https://www.pharmiweb.com/press-release/2025-10-15/newleos-therapeutics-ceo-david-donabedian-recognized-by-goldman-sachs-as-one-of-the-most-exceptional

    PHARMIWEB
    15 Oct 2025
    Share Share
    Newleos Therapeutics Advances Neuropsychiatric Pipeline Progress
    Newleos Therapeutics Advances Neuropsychiatric Pipeline Progress

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250930298807/en/Newleos-Therapeutics-Announces-Clinical-Progress-Across-Neuropsychiatric-Pipeline

    BUSINESSWIRE
    30 Sep 2025
    Share Share
    Newleos Posts 2025 Psychiatry Congress Data in Poster Session
    Newleos Posts 2025 Psychiatry Congress Data in Poster Session

    09 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250909945977/en/Newleos-Therapeutics-Announces-Poster-Presentation-to-be-Featured-at-the-2025-World-Congress-of-Biological-Psychiatry

    BUSINESSWIRE
    09 Sep 2025
    Share Share
    Newleos Adds Stephen Brannan to Board, Updates on NTX-1955
    Newleos Adds Stephen Brannan to Board, Updates on NTX-1955

    23 Jul 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250723893290/en/Newleos-Therapeutics-Appoints-Stephen-Brannan-to-Board-of-Directors-and-Announces-NTX-1955-Clinical-Progress-in-Generalized-Anxiety-Disorder

    BUSINESSWIRE
    23 Jul 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search